Search

Search Constraints

You searched for: Author/Creator Arnott, Ian

Search Results

1. Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel. Issue 10 (8th June 2020)

2. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Issue 6 (17th April 2020)

3. Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational study. Issue 3 (24th January 2014)

4. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (February 2022)

7. Inflammatory bowel disease patient‐reported quality assessment should drive service improvement: a national survey of UK IBD units and patients. Issue 4 (1st June 2022)

8. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. (September 2016)

9. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial. (December 2016)